Veriskin
PrivateLast Round
Seed
Nov 10, 2022
Total Funding Raised
$8.03M
Company Overview
Veriskin is a medical device company that develops TruScore, a non-invasive, handheld diagnostic device that uses AI and hemodynamic measurements to assist clinicians in the rapid detection of skin cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Veriskin Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Veriskin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 10, 2022 | ||||
| Grant | Jul 14, 2022 | ||||
| Grant | Sep 22, 2021 | ||||
| Grant | Mar 1, 2020 | ||||
| Grant | May 1, 2016 |
Veriskin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Arizona Tech Investors | Seed |
| NIH RADx | Grant |
| Frontier Angels | Seed |
| Ariel Savannah Angel Partners | Seed |
| TiE SoCal Angels | Seed |
| DigiLife | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 14, 2022
$3M grant received from National Cancer Institute and NIH RADx.
Veriskin Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Veriskin's valuation, stock price, and market status.